Global Colorectal Cancer Diagnostic Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Colorectal Cancer Diagnostic Revenue
• 1.4 Market by Type
  • 1.4.1 Global Colorectal Cancer Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Fecal Occult Blood Test
  • 1.4.3 Biomarker Test
  • 1.4.4 CRC DNA Screening Test
• 1.5 Market by Application
  • 1.5.1 Global Colorectal Cancer Diagnostic Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Ambulatory Surgical Centers
  • 1.5.4 Diagnostic Centers
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Colorectal Cancer Diagnostic Market Perspective (2015-2026)
• 2.2 Global Colorectal Cancer Diagnostic Growth Trends by Regions
  • 2.2.1 Colorectal Cancer Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Colorectal Cancer Diagnostic Historic Market Share by Regions (2015-2020)
  • 2.2.3 Colorectal Cancer Diagnostic Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Colorectal Cancer Diagnostic Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Colorectal Cancer Diagnostic Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Colorectal Cancer Diagnostic Players by Market Size
  • 3.1.1 Global Top Colorectal Cancer Diagnostic Players by Revenue (2015-2020)
  • 3.1.2 Global Colorectal Cancer Diagnostic Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Colorectal Cancer Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Colorectal Cancer Diagnostic Market Concentration Ratio
  • 3.2.1 Global Colorectal Cancer Diagnostic Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnostic Revenue in 2019
• 3.3 Colorectal Cancer Diagnostic Key Players Head office and Area Served
• 3.4 Key Players Colorectal Cancer Diagnostic Product Solution and Service
• 3.5 Date of Enter into Colorectal Cancer Diagnostic Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Colorectal Cancer Diagnostic Historic Market Size by Type (2015-2020)
• 4.2 Global Colorectal Cancer Diagnostic Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Colorectal Cancer Diagnostic Market Size by Application (2015-2020)
• 5.2 Global Colorectal Cancer Diagnostic Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Colorectal Cancer Diagnostic Market Size (2015-2020)
• 6.2 Colorectal Cancer Diagnostic Key Players in North America (2019-2020)
• 6.3 North America Colorectal Cancer Diagnostic Market Size by Type (2015-2020)
• 6.4 North America Colorectal Cancer Diagnostic Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Colorectal Cancer Diagnostic Market Size (2015-2020)
• 7.2 Colorectal Cancer Diagnostic Key Players in Europe (2019-2020)
• 7.3 Europe Colorectal Cancer Diagnostic Market Size by Type (2015-2020)
• 7.4 Europe Colorectal Cancer Diagnostic Market Size by Application (2015-2020)

8 China

• 8.1 China Colorectal Cancer Diagnostic Market Size (2015-2020)
• 8.2 Colorectal Cancer Diagnostic Key Players in China (2019-2020)
• 8.3 China Colorectal Cancer Diagnostic Market Size by Type (2015-2020)
• 8.4 China Colorectal Cancer Diagnostic Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Colorectal Cancer Diagnostic Market Size (2015-2020)
• 9.2 Colorectal Cancer Diagnostic Key Players in Japan (2019-2020)
• 9.3 Japan Colorectal Cancer Diagnostic Market Size by Type (2015-2020)
• 9.4 Japan Colorectal Cancer Diagnostic Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Colorectal Cancer Diagnostic Market Size (2015-2020)
• 10.2 Colorectal Cancer Diagnostic Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Colorectal Cancer Diagnostic Market Size by Type (2015-2020)
• 10.4 Southeast Asia Colorectal Cancer Diagnostic Market Size by Application (2015-2020)

11 India

• 11.1 India Colorectal Cancer Diagnostic Market Size (2015-2020)
• 11.2 Colorectal Cancer Diagnostic Key Players in India (2019-2020)
• 11.3 India Colorectal Cancer Diagnostic Market Size by Type (2015-2020)
• 11.4 India Colorectal Cancer Diagnostic Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Colorectal Cancer Diagnostic Market Size (2015-2020)
• 12.2 Colorectal Cancer Diagnostic Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Colorectal Cancer Diagnostic Market Size by Type (2015-2020)
• 12.4 Central & South America Colorectal Cancer Diagnostic Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott Molecular
  • 13.1.1 Abbott Molecular Company Details
  • 13.1.2 Abbott Molecular Business Overview
  • 13.1.3 Abbott Molecular Colorectal Cancer Diagnostic Introduction
  • 13.1.4 Abbott Molecular Revenue in Colorectal Cancer Diagnostic Business (2015-2020))
  • 13.1.5 Abbott Molecular Recent Development
• 13.2 Abbott
  • 13.2.1 Abbott Company Details
  • 13.2.2 Abbott Business Overview
  • 13.2.3 Abbott Colorectal Cancer Diagnostic Introduction
  • 13.2.4 Abbott Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 13.2.5 Abbott Recent Development
• 13.3 Beckman Coulter
  • 13.3.1 Beckman Coulter Company Details
  • 13.3.2 Beckman Coulter Business Overview
  • 13.3.3 Beckman Coulter Colorectal Cancer Diagnostic Introduction
  • 13.3.4 Beckman Coulter Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 13.3.5 Beckman Coulter Recent Development
• 13.4 Eiken Chemical
  • 13.4.1 Eiken Chemical Company Details
  • 13.4.2 Eiken Chemical Business Overview
  • 13.4.3 Eiken Chemical Colorectal Cancer Diagnostic Introduction
  • 13.4.4 Eiken Chemical Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 13.4.5 Eiken Chemical Recent Development
• 13.5 Epigenomics
  • 13.5.1 Epigenomics Company Details
  • 13.5.2 Epigenomics Business Overview
  • 13.5.3 Epigenomics Colorectal Cancer Diagnostic Introduction
  • 13.5.4 Epigenomics Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 13.5.5 Epigenomics Recent Development
• 13.6 Sysmex
  • 13.6.1 Sysmex Company Details
  • 13.6.2 Sysmex Business Overview
  • 13.6.3 Sysmex Colorectal Cancer Diagnostic Introduction
  • 13.6.4 Sysmex Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 13.6.5 Sysmex Recent Development
• 13.7 Siemens Healthcare
  • 13.7.1 Siemens Healthcare Company Details
  • 13.7.2 Siemens Healthcare Business Overview
  • 13.7.3 Siemens Healthcare Colorectal Cancer Diagnostic Introduction
  • 13.7.4 Siemens Healthcare Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 13.7.5 Siemens Healthcare Recent Development
• 13.8 Quest Diagnostics
  • 13.8.1 Quest Diagnostics Company Details
  • 13.8.2 Quest Diagnostics Business Overview
  • 13.8.3 Quest Diagnostics Colorectal Cancer Diagnostic Introduction
  • 13.8.4 Quest Diagnostics Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 13.8.5 Quest Diagnostics Recent Development
• 13.9 CompanianDx
  • 13.9.1 CompanianDx Company Details
  • 13.9.2 CompanianDx Business Overview
  • 13.9.3 CompanianDx Colorectal Cancer Diagnostic Introduction
  • 13.9.4 CompanianDx Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 13.9.5 CompanianDx Recent Development
• 13.10 BioTime
  • 13.10.1 BioTime Company Details
  • 13.10.2 BioTime Business Overview
  • 13.10.3 BioTime Colorectal Cancer Diagnostic Introduction
  • 13.10.4 BioTime Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 13.10.5 BioTime Recent Development
• 13.11 Merck Millipore
  • 10.11.1 Merck Millipore Company Details
  • 10.11.2 Merck Millipore Business Overview
  • 10.11.3 Merck Millipore Colorectal Cancer Diagnostic Introduction
  • 10.11.4 Merck Millipore Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 10.11.5 Merck Millipore Recent Development
• 13.12 GeneNews
  • 10.12.1 GeneNews Company Details
  • 10.12.2 GeneNews Business Overview
  • 10.12.3 GeneNews Colorectal Cancer Diagnostic Introduction
  • 10.12.4 GeneNews Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 10.12.5 GeneNews Recent Development
• 13.13 BioMarCare
  • 10.13.1 BioMarCare Company Details
  • 10.13.2 BioMarCare Business Overview
  • 10.13.3 BioMarCare Colorectal Cancer Diagnostic Introduction
  • 10.13.4 BioMarCare Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 10.13.5 BioMarCare Recent Development
• 13.14 Immunostics
  • 10.14.1 Immunostics Company Details
  • 10.14.2 Immunostics Business Overview
  • 10.14.3 Immunostics Colorectal Cancer Diagnostic Introduction
  • 10.14.4 Immunostics Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 10.14.5 Immunostics Recent Development
• 13.15 ExiQon
  • 10.15.1 ExiQon Company Details
  • 10.15.2 ExiQon Business Overview
  • 10.15.3 ExiQon Colorectal Cancer Diagnostic Introduction
  • 10.15.4 ExiQon Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 10.15.5 ExiQon Recent Development
• 13.16 Mode Diagnostics
  • 10.16.1 Mode Diagnostics Company Details
  • 10.16.2 Mode Diagnostics Business Overview
  • 10.16.3 Mode Diagnostics Colorectal Cancer Diagnostic Introduction
  • 10.16.4 Mode Diagnostics Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 10.16.5 Mode Diagnostics Recent Development
• 13.17 Randox
  • 10.17.1 Randox Company Details
  • 10.17.2 Randox Business Overview
  • 10.17.3 Randox Colorectal Cancer Diagnostic Introduction
  • 10.17.4 Randox Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 10.17.5 Randox Recent Development
• 13.18 R-Biopharm
  • 10.18.1 R-Biopharm Company Details
  • 10.18.2 R-Biopharm Business Overview
  • 10.18.3 R-Biopharm Colorectal Cancer Diagnostic Introduction
  • 10.18.4 R-Biopharm Revenue in Colorectal Cancer Diagnostic Business (2015-2020)
  • 10.18.5 R-Biopharm Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer